Biotech

All Articles

Galapagos' stockpile as fund shows intent to form its own evolution

.Galapagos is coming under additional stress from financiers. Having built a 9.9% stake in Galapagos...

Cell- centered Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings as...

Allist settles Jacobio $21M, landing part in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased itself a starring character in China's KRAS ...

ReNeuron leaving behind intention exchange after missing fundraising objective

.ReNeuron has joined the lengthy listing of biotechs to leave London's intention stock market. The s...

MBX files for IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has actually included in the latest outbreak of IPO filings. The biotech, which sub...

FDA broadens probing right into Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the firm's prospective MDMA-assisted treatment for post-traumatic stress disor...

Gene editor Tome giving up 131 workers

.Merely days after genetics editor Tome Biosciences revealed hidden operational slices, a more clear...

Repare gives up 25% of workers as biotech halts preclinical R&ampD

.Repare Rehab is actually giving up an one-fourth of its own labor force as the oncology biotech sca...

J &amp J files for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten one more measure toward understanding a yield on its $6.5 billion n...

Gain's phase 1 succeed paves means to show Parkinson's drug's worth

.Increase Rehabs has actually prepared its direct verifying the performance of its Parkinson's ailme...